New Delhi: A US court dismissed a case against Sun Pharmaceutical Industries Ltd and its US subsidiary Caraco Pharmaceutical Laboratories Ltd last week. The case was filed by US-based Wyeth Pharmaceuticals, which had sued Sun and Caraco for claiming that their heartburn drug was a generic version of its Protonix drug.
On 2 March the US district court for the Eastern District of Michigan dismissed Wyeth’s complaint asking the company to approach the US Food and Drug Administration first since marketing approval to Sun to sell the drug in the US was granted by them.
Wyeth was seeking $75,000 in damages from Sun. “The court has told Wyeth that if it is claiming that Sun’s drug is different from its own drug then it is for the FDA to decide. If the FDA decides it is different then Wyeth can approach the court again,” explained a spokesperson for Sun Pharma.